Wu.S2013, et.al [54–56] reported that Aidi injection with chemotherapy could significantly improve the percentage of CD3+T cells, CD4+T cells, CD8+T cells and NK cells and the CD4+/CD8+ T cells ratio in peripheral blood, and improve tumor immunity of patient with NSCLC. This evidence concerns the gene CD8A and non-small cell lung carcinoma.